新聞/Reuters/Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationDualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationRefinitiv閱讀少於1分鐘9606Duality Biotherapeutics Inc 9606:DUALITYBIO'S NEXT-GENERATION HER3 ADC DB-1310 GRANTED FDA FAST TRACK DESIGNATIONReuters中國股票亞洲美國股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
